CompletedNot Applicable

The Effect of Electro-fetal monıtorısıon Sound on Anxiety, paın and Postpartum Bonding at the First Phase of Delivery

Turkey (Türkiye)80 participantsStarted 2021-11-24

Plain-language summary

University of Health Sciences, Istanbul Umraniye training and Research Hospital, Clinic of Obstetrics and gynecology, birth, maternity and Child Health Hospital, Aydın to the clinic, pregnant women, pregnant women in active labor act, and received acceptance to delivery to the fetal heart sound by existing tripped; fetal heart sounds of pregnant women, anxiety, pain and the birth in order to determine the effect of connecting the end of the level will be conducted. The study will guide midwives in reducing the anxiety or pain of pregnant women.

Who can participate

Age range

18 Years – 35 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Who are december the age range of 18- 35, * The least literate, * Which is the primiparous, * who is at the 38-42 week of gestation * With a single pregnancy in the vertex position, * Who does not have a systemic disease that will interfere with normal delivery (gestational diabetes, preeclampsia, etc.), * Who is in the active phase of labor \* Pregnant women who have agreed to participate in the study and received informed consent will be included in the study Exclusion Criteria: * 37\. week 42. not between the weeks dec * It is a multipart, * Anyone who has any problems with communication, * Who has ceased to be involved in the study, * An unexpected complication develops (cesarean section of the pregnant woman, development of fetal distress in the fetus, etc.). * Oxytocin induction is applied Pregnant women who have been given pain medication (Aldolan, diazem) are

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

VİSUAL ANALOG SCALE

Timeframe: immediately Before application

STATUS AND CONTINUOUS ANXIETY SCALE

Timeframe: immediately Before application

Trial details

NCT IDNCT06271889

SponsorSaglik Bilimleri Universitesi

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-08-24

View on ClinicalTrials.gov More Delivery Fear trials